What is iSIMPATHY?
iSIMPATHY is an EU funded project running until March 2023 across the three jurisdictions of Northern Ireland, Scotland and the border areas of the Republic of Ireland. The project ensures the best and most sustainable outcomes with medication use in patients taking multiple medicines. iSIMPATHY helps enable patients to lead healthy and active lives by supporting both them and clinicians to define and achieve realistic goals of drug treatment through medicine reviews.
The project is training healthcare professionals who will deliver 15,000 effective medicine reviews by the end of March 2023. The project delivers the key principles of the WHO Third Global patient safety challenge, medication without harm. The project is delivering a systems approach that is scalable through cross-border shared learning.
The iSIMPATHY project is delivering the following:
- Recruiting and training 10.5 (WTE) Pharmacists to deliver medicine reviews.
- Training 120 additional health professionals
- to embed medicines reviews beyond the lifespan of the project by delivering the 7-step polypharmacy review as well as understand the benefits and refer to another health professional where appropriate.
- Delivering 15,000 polypharmacy (medicine) reviews using the 7-step process by the end of the project. The majority of these will be delivered by the dedicated project pharmacists, but some may come from the additional pharmacists and doctors we will train.